期刊文献+

LC-MS-MS法测定人血浆中阿托伐他汀浓度 被引量:5

Determination of Atorvastatin in human plasma by LC-MS-MS
下载PDF
导出
摘要 目的 建立液质联用色谱法(LC-MS-MS)测定人血浆中阿托伐他汀(atorvastatin)浓度。方法 采用萃取法处理血浆样品进行LC-MS-MS分析。分析柱为美国Thermo公司Thermo BioBasic-C8柱(2.1mm×100mm,5μm);流动相为乙腈(含0.1%甲酸):水(含0.1%甲酸)=70:30;流速0.3ml/min;质谱条件:电喷雾离子化电离源ESI负离子检测,喷雾电压(SP)3500KV,鞘气(SGP)流速10Arb,辅助气(AGP)流速15Arb,毛细管温度(TEM)314℃;选择反应监测(SRM)分别测定阿托伐他汀和甲苯磺丁脲558→278m/z(30EV)和269→106m/z(22EV)。结果 阿托伐他汀在0.1~20μg/L检测浓度范围内呈良好线性关系(r〉0.99),最低定量限(LLOQ)为0.1μg/L,绝对回收率在70%以上,高中低3种浓度的日内和日间RSD≤15%。结论 该方法操作简便、灵敏、准确,适用于临床阿托伐他汀的血药浓度监测及I期临床试验。 Objective To establish a method for determining Atorvastatin in human plasma by LC-MS-MS. Methods Atorvastatin was extracted for determination by LC-MS-MS. Analytical column was Thermo BioBasic-Cs (2.1mm×100mm,5μm). The mobile phase was acetonitrile(0.1% acid) : water(0.1% acid) =70:30. Mass spectrum conditions was ESI performing in the SRM mode using target ions m/z 558→278(30EV)( Atorvastatin ), m/z269→106(22 EV)(tolbutamide), SP 3 500 KV, SGP 10 Arb, AGP 15 Arb, TEM 314℃. Results The calibration curve was linear over the range of 0.1-20μg/L. The LLOQ of Atorvastatin in plasma was 0.1μg/L. The extracted recovery was 〉70%. The intra-and inter-day RSD were 〈 15%. Conclusion The method is sensitive, simple and accurate to determinate Atorvastatin plasma concentration and suitable to study phase I clinical test of Atorvastatin.
出处 《药学实践杂志》 CAS 2011年第1期15-16,70,共3页 Journal of Pharmaceutical Practice
关键词 阿托伐他汀钙 血药浓度 液质联用色谱法 Atorvastatin plasma concentration LC-MS-MS
  • 相关文献

参考文献4

二级参考文献22

  • 1李桦,阮金秀,杨进生.T-2毒素及其代谢产物在大鼠胆汁中的排泄和肠肝循环[J].卫生毒理学杂志,1993,7(2):89-91. 被引量:5
  • 2邸晓辉,杨永革,梅巍,刘静,许雪廷.阿托伐他汀钙胶囊的人体生物等效性研究[J].解放军药学学报,2005,21(4):262-265. 被引量:8
  • 3[1]Chong PH,Seeger JD,Franklin C.Clinically relevant differences between the statins:implications for therapeutic selection[J].Am Jmed,2001,111 (2):390-400.
  • 4[2]Fukazawa I,Uchida N,Uchida E,et al.Effect of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese[J].Br J Clin Pharmacol,2003,57 (4):448-455.
  • 5[3]Hermann M,Christensen H,Reubsaet JLE.Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS[J].Anal Bioanal Chem,2005,382 (10):1242-1249.
  • 6[4]Gibson DM,Stern RH,Abel RB,et al.Absolute bioavailability of atorvastatin in man[J].Pharm Res,1997,14(6):253.
  • 7[5]Bullen WW,Miller RA,Hayes RN.Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin,ortho-hydroxy atorvastatin,and para-hydroxy atorvastatin in human,dog,and rat plasma[J].J Am Soc Mass Spectrom,1999,10 (1):55-66.
  • 8[6]Hermann M,Christensen H,Reubsaet JLE.Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS[J].Anal Bioanal Chem,2005,382 (10):1242-1249.
  • 9[7]Borek-Dohalsk V,Huclová J,Barrett B,et al.Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma-pharmacokinetic study[J].Anal Bioanal Chem,2006,386 (2):275-285.
  • 10[8]Ramakrishna NVS,Koteshwara M,Vishwottam KN,et al.Simple,sensitive and rapid LC-MS-MS method for the quantitation of cerivastatin in human plasma-application to pharmacokine-tic studies[J].Pharma.& Biomedi Anal,2004,36(8):505-515.

共引文献17

同被引文献39

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部